Biotech

All Articles

Charles Baum takes control of Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapeutics' $ 5.8 billion sale to Bristol Myers ...

Asarina to shut after efforts to partner Tourette's drug fall short

.After communicating to more than 200 companies to partner a Tourette disorder treatment that reveal...

Novartis pens $150M in advance bispecifics cope with Dren Bio

.Novartis has actually possessed some rotten luck along with bispecific antibodies previously, howev...

AstraZeneca plants an EGFR tree with Pinetree offer worth $45M

.Pinetree Therapies will certainly assist AstraZeneca vegetation some trees in its pipeline with a b...

GRO collects $60M collection B to take gout arthritis treatment in to center

.GRO Biosciences has actually finished the full week with an added $60.3 thousand in the banking com...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses CEO

.Accept to today's Chutes &amp Ladders, our summary of considerable management hirings, firings and ...